These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 21980433)

  • 41. SOCS2 induces neurite outgrowth by regulation of epidermal growth factor receptor activation.
    Goldshmit Y; Walters CE; Scott HJ; Greenhalgh CJ; Turnley AM
    J Biol Chem; 2004 Apr; 279(16):16349-55. PubMed ID: 14764607
    [TBL] [Abstract][Full Text] [Related]  

  • 42. βTrCP controls GH receptor degradation via two different motifs.
    da Silva Almeida AC; Strous GJ; van Rossum AG
    Mol Endocrinol; 2012 Jan; 26(1):165-77. PubMed ID: 22034227
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Vitamin D3 cannot revert desensitization of growth hormone (GH)-induced STAT5-signaling in GH-overexpressing mice non-calcemic tissues.
    Sotelo AI; Miquet JG; González L; Bartke A; Turyn D
    Growth Horm IGF Res; 2008 Apr; 18(2):148-56. PubMed ID: 17881271
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ligand-independent growth hormone receptor dimerization occurs in the endoplasmic reticulum and is required for ubiquitin system-dependent endocytosis.
    Gent J; van Kerkhof P; Roza M; Bu G; Strous GJ
    Proc Natl Acad Sci U S A; 2002 Jul; 99(15):9858-63. PubMed ID: 12105275
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells.
    Weiss-Messer E; Merom O; Adi A; Karry R; Bidosee M; Ber R; Kaploun A; Stein A; Barkey RJ
    Mol Cell Endocrinol; 2004 May; 220(1-2):109-23. PubMed ID: 15196705
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Termination of growth hormone pulse-induced STAT5b signaling.
    Gebert CA; Park SH; Waxman DJ
    Mol Endocrinol; 1999 Jan; 13(1):38-56. PubMed ID: 9892011
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serendipitous SAD Solution for DMSO-Soaked SOCS2-ElonginC-ElonginB Crystals Using Covalently Incorporated Dimethylarsenic: Insights into Substrate Receptor Conformational Flexibility in Cullin RING Ligases.
    Gadd MS; Bulatov E; Ciulli A
    PLoS One; 2015; 10(6):e0131218. PubMed ID: 26121586
    [TBL] [Abstract][Full Text] [Related]  

  • 48. SOCS2 mediates the cross talk between androgen and growth hormone signaling in prostate cancer.
    Iglesias-Gato D; Chuan YC; Wikström P; Augsten S; Jiang N; Niu Y; Seipel A; Danneman D; Vermeij M; Fernandez-Perez L; Jenster G; Egevad L; Norstedt G; Flores-Morales A
    Carcinogenesis; 2014 Jan; 35(1):24-33. PubMed ID: 24031028
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Preparation and expression of biologically active prolactin and growth hormone receptors and suppressor of cytokine signaling proteins 1, 2, 3, and 6 tagged with cyan and yellow fluorescent proteins.
    Ben-Yair L; Slaaby R; Herman A; Cohen Y; Biener E; Moran N; Yoshimura A; Whittaker J; De Meyts P; Herman B; Gertler A
    Protein Expr Purif; 2002 Aug; 25(3):456-64. PubMed ID: 12182826
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparative analysis of CNS populations in knockout mice with altered growth hormone responsiveness.
    Ransome MI; Goldshmit Y; Bartlett PF; Waters MJ; Turnley AM
    Eur J Neurosci; 2004 Apr; 19(8):2069-79. PubMed ID: 15090034
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Suppressor of cytokine signaling-2 deficiency induces molecular and metabolic changes that partially overlap with growth hormone-dependent effects.
    Rico-Bautista E; Greenhalgh CJ; Tollet-Egnell P; Hilton DJ; Alexander WS; Norstedt G; Flores-Morales A
    Mol Endocrinol; 2005 Mar; 19(3):781-93. PubMed ID: 15563548
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vivo targeting of the growth hormone receptor (GHR) Box1 sequence demonstrates that the GHR does not signal exclusively through JAK2.
    Barclay JL; Kerr LM; Arthur L; Rowland JE; Nelson CN; Ishikawa M; d'Aniello EM; White M; Noakes PG; Waters MJ
    Mol Endocrinol; 2010 Jan; 24(1):204-17. PubMed ID: 19884384
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Activation of growth hormone receptors by growth hormone and growth hormone antagonist dimers: insights into receptor triggering.
    Yang N; Langenheim JF; Wang X; Jiang J; Chen WY; Frank SJ
    Mol Endocrinol; 2008 Apr; 22(4):978-88. PubMed ID: 18096690
    [TBL] [Abstract][Full Text] [Related]  

  • 54. SOCS2 is the critical regulator of GH action in murine growth plate chondrogenesis.
    Pass C; MacRae VE; Huesa C; Faisal Ahmed S; Farquharson C
    J Bone Miner Res; 2012 May; 27(5):1055-66. PubMed ID: 22228213
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Src transduces signaling via growth hormone (GH)-activated GH receptor (GHR) tyrosine-phosphorylating GHR and STAT5 in human leukemia cells.
    Manabe N; Kubota Y; Kitanaka A; Ohnishi H; Taminato T; Tanaka T
    Leuk Res; 2006 Nov; 30(11):1391-8. PubMed ID: 16650892
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vivo transcript profiling and phylogenetic analysis identifies suppressor of cytokine signaling 2 as a direct signal transducer and activator of transcription 5b target in liver.
    Vidal OM; Merino R; Rico-Bautista E; Fernandez-Perez L; Chia DJ; Woelfle J; Ono M; Lenhard B; Norstedt G; Rotwein P; Flores-Morales A
    Mol Endocrinol; 2007 Jan; 21(1):293-311. PubMed ID: 17008382
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Growth hormone-promoted tyrosyl phosphorylation of SHC proteins and SHC association with Grb2.
    VanderKuur J; Allevato G; Billestrup N; Norstedt G; Carter-Su C
    J Biol Chem; 1995 Mar; 270(13):7587-93. PubMed ID: 7535773
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A novel Y332C missense mutation in the intracellular domain of the human growth hormone receptor does not alter STAT5b signaling: redundancy of GHR intracellular tyrosines involved in STAT5b signaling.
    Derr MA; Fang P; Sinha SK; Ten S; Hwa V; Rosenfeld RG
    Horm Res Paediatr; 2011; 75(3):187-99. PubMed ID: 20962506
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase.
    Argetsinger LS; Campbell GS; Yang X; Witthuhn BA; Silvennoinen O; Ihle JN; Carter-Su C
    Cell; 1993 Jul; 74(2):237-44. PubMed ID: 8343952
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Growth hormone-dependent phosphorylation of tyrosine 333 and/or 338 of the growth hormone receptor.
    VanderKuur JA; Wang X; Zhang L; Allevato G; Billestrup N; Carter-Su C
    J Biol Chem; 1995 Sep; 270(37):21738-44. PubMed ID: 7545168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.